T1	disease_or_phenotypic_feature 13 45	pancreatic ductal adenocarcinoma
T2	chemical 57 64	antigen
T3	chemical 95 105	paclitaxel
T4	chemical 133 145	Tirapazamine
T5	chemical 153 157	drug
T6	chemical 198 206	platinum
T7	disease_or_phenotypic_feature 229 255	non-small-cell lung cancer
T8	chemical 299 318	parathyroid hormone
T9	chemical 320 323	PTH
T10	disease_or_phenotypic_feature 338 351	hypercalcemia
T11	chemical 352 359	hormone
T12	chemical 386 390	drug
T13	chemical 422 432	lorcaserin
T14	disease_or_phenotypic_feature 454 461	obesity
T15	chemical 474 480	oxygen
T16	disease_or_phenotypic_feature 536 542	autism
T17	chemical 590 596	saline
T18	chemical 598 608	furosemide
T19	chemical 613 623	prednisone
T20	disease_or_phenotypic_feature 649 662	hypercalcemia
T21	disease_or_phenotypic_feature 667 680	renal failure
T22	chemical 683 694	Biochemical
T23	disease_or_phenotypic_feature 715 723	cataract
T24	chemical 735 746	Amfepramone
T25	chemical 748 762	diethylpropion
T26	chemical 791 795	drug
T27	disease_or_phenotypic_feature 837 844	obesity
T28	chemical 862 870	estrogen
T29	chemical 964 970	saline
T30	chemical 982 989	glucose
T31	disease_or_phenotypic_feature 991 1004	hyperglycemia
T32	disease_or_phenotypic_feature 1005 1021	hyperinsulinemia
T33	chemical 1024 1031	glucose
T34	disease_or_phenotypic_feature 1046 1062	hyperinsulinemia
T35	chemical 1070 1079	diazoxide
T36	chemical 1100 1107	glucose
T37	disease_or_phenotypic_feature 1118 1131	hyperglycemia
T38	chemical 1145 1152	hormone
T39	disease_or_phenotypic_feature 1186 1204	hyperprolactinemia
T40	disease_or_phenotypic_feature 1226 1238	hypogonadism
T41	chemical 1257 1266	oxidative
T42	disease_or_phenotypic_feature 1277 1284	obesity
T43	disease_or_phenotypic_feature 1293 1307	glomerulopathy
T44	disease_or_phenotypic_feature 1348 1355	obesity
T45	disease_or_phenotypic_feature 1417 1424	obesity
T46	chemical 1430 1438	hormonal
T47	chemical 1542 1549	biology
T48	disease_or_phenotypic_feature 1565 1572	obesity
T49	chemical 1574 1582	Estrogen
T50	disease_or_phenotypic_feature 1583 1592	dependent
T51	disease_or_phenotypic_feature 1616 1622	facial
T52	disease_or_phenotypic_feature 1640 1645	edema
T53	chemical 1657 1676	antibacterial drugs
T54	chemical 1681 1694	streptokinase
T55	chemical 1712 1722	Cinacalcet
T56	disease_or_phenotypic_feature 1769 1782	hypercalcemic
T57	disease_or_phenotypic_feature 1783 1802	hyperparathyroidism
T58	chemical 1837 1844	mineral
T59	chemical 1880 1899	parathyroid hormone
T60	chemical 1923 1929	oxygen
T61	disease_or_phenotypic_feature 1959 1972	breast cancer
T62	disease_or_phenotypic_feature 2112 2134	malignant hyperthermia
T63	chemical 2150 2160	dantrolene
T64	chemical 2161 2167	sodium
T65	chemical 2261 2269	antigens
T66	chemical 2273 2280	antigen
T67	chemical 2282 2285	ras
T68	chemical 2295 2298	ras
T69	disease_or_phenotypic_feature 2361 2375	bladder cancer
T70	chemical 2415 2422	antigen
T71	disease_or_phenotypic_feature 2445 2451	cancer
T72	chemical 2515 2522	antigen
T73	chemical 2528 2535	antigen
T74	disease_or_phenotypic_feature 2552 2560	seminoma
T75	chemical 2562 2565	HCG
T76	disease_or_phenotypic_feature 2575 2583	seminoma
T77	disease_or_phenotypic_feature 2592 2604	seminomatous
R1	treats Arg1:T2 Arg2:T1	
R2	treats Arg1:T3 Arg2:T1	
R3	treats Arg1:T4 Arg2:T7	
R4	treats Arg1:T6 Arg2:T7	
R5	treats Arg1:T13 Arg2:T14	
R6	treats Arg1:T15 Arg2:T16	
R7	treats Arg1:T17 Arg2:T20	
R8	treats Arg1:T17 Arg2:T21	
R9	treats Arg1:T18 Arg2:T20	
R10	treats Arg1:T18 Arg2:T21	
R11	treats Arg1:T19 Arg2:T20	
R12	treats Arg1:T19 Arg2:T21	
R13	treats Arg1:T24 Arg2:T27	
R14	treats Arg1:T24 Arg2:T27	
R17	causes_or_contributes_to Arg1:T38 Arg2:T39	
T78	missed_disease_or_phenotypic_feature 1209 1238	hypogonadotpopic hypogonadism
T79	corrected_disease_or_phenotypic_feature 1574 1599	Estrogen-dependent tumors
R19	causes_or_contributes_to Arg1:T49 Arg2:T79	
T80	corrected_disease_or_phenotypic_feature 1277 1307	obesity-related glomerulopathy
T81	corrected_disease_or_phenotypic_feature 1616 1635	facial inflammation
R21	treats Arg1:T53 Arg2:T52	
R22	treats Arg1:T53 Arg2:T81	
R23	treats Arg1:T54 Arg2:T52	
R24	treats Arg1:T54 Arg2:T81	
R25	treats Arg1:T55 Arg2:T56	
R26	treats Arg1:T55 Arg2:T57	
T82	corrected_chemical 2150 2167	dantrolene sodium
R27	treats Arg1:T82 Arg2:T62	
T83	DONE 2628 2632	DONE
T84	missed_chemical 113 131	PLGA nanoparticles
R28	treats Arg1:T84 Arg2:T1	
T85	missed_chemical 770 795	appetite-suppressant drug
R15	treats Arg1:T85 Arg2:T27	
R16	treats Arg1:T85 Arg2:T27	
T86	missed_disease_or_phenotypic_feature 1257 1273	oxidative stress
